Nanobody-targeted photodynamic therapy induces significant tumor regression of trastuzumab-resistant HER2-positive breast cancer, after a single treatment session

M M Deken; MM Kijanka; IB Hernandez; MD Slooter; Riëtte Bruijn; P van Diest; P Henegouwen; C Lowik; Dominic Robinson; AL Vahrmeijer; S Oliveira

doi:10.1016/j.jconrel.2020.04.030

Nanobody-targeted photodynamic therapy induces significant tumor regression of trastuzumab-resistant HER2-positive breast cancer, after a single treatment session

M M Deken, MM Kijanka, IB Hernandez, MD Slooter, Riëtte Bruijn, P van Diest, P Henegouwen, C Lowik, Dominic Robinson, AL Vahrmeijer, S Oliveira

Research output: Contribution to journal › Article › Academic › peer-review

32 Citations (Scopus)

9 Downloads (Pure)

Original language	English
Pages (from-to)	269-281
Number of pages	13
Journal	Journal of Controlled Release
Volume	323
DOIs	https://doi.org/10.1016/j.jconrel.2020.04.030
Publication status	Published - 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.jconrel.2020.04.030

Repub_126535_O-A.pdfFinal published version, 3.11 MB

http://hdl.handle.net/1765/126535

Cite this

Deken, M. M., Kijanka, MM., Hernandez, IB., Slooter, MD., Bruijn, R., van Diest, P., Henegouwen, P., Lowik, C., Robinson, D., Vahrmeijer, AL., & Oliveira, S. (2020). Nanobody-targeted photodynamic therapy induces significant tumor regression of trastuzumab-resistant HER2-positive breast cancer, after a single treatment session. Journal of Controlled Release, 323, 269-281. https://doi.org/10.1016/j.jconrel.2020.04.030

@article{0dc00a71048f4654b4b0f9d5409c7146,

title = "Nanobody-targeted photodynamic therapy induces significant tumor regression of trastuzumab-resistant HER2-positive breast cancer, after a single treatment session",

author = "Deken, {M M} and MM Kijanka and IB Hernandez and MD Slooter and Ri{\"e}tte Bruijn and {van Diest}, P and P Henegouwen and C Lowik and Dominic Robinson and AL Vahrmeijer and S Oliveira",

year = "2020",

doi = "10.1016/j.jconrel.2020.04.030",

language = "English",

volume = "323",

pages = "269--281",

journal = "Journal of Controlled Release",

issn = "0168-3659",

publisher = "Elsevier",

}

Deken, MM, Kijanka, MM, Hernandez, IB, Slooter, MD, Bruijn, R, van Diest, P, Henegouwen, P, Lowik, C , Robinson, D, Vahrmeijer, AL & Oliveira, S 2020, 'Nanobody-targeted photodynamic therapy induces significant tumor regression of trastuzumab-resistant HER2-positive breast cancer, after a single treatment session', Journal of Controlled Release, vol. 323, pp. 269-281. https://doi.org/10.1016/j.jconrel.2020.04.030

TY - JOUR

T1 - Nanobody-targeted photodynamic therapy induces significant tumor regression of trastuzumab-resistant HER2-positive breast cancer, after a single treatment session

AU - Deken, M M

AU - Kijanka, MM

AU - Hernandez, IB

AU - Slooter, MD

AU - Bruijn, Riëtte

AU - van Diest, P

AU - Henegouwen, P

AU - Lowik, C

AU - Robinson, Dominic

AU - Vahrmeijer, AL

AU - Oliveira, S

PY - 2020

Y1 - 2020

U2 - 10.1016/j.jconrel.2020.04.030

DO - 10.1016/j.jconrel.2020.04.030

M3 - Article

SN - 0168-3659

VL - 323

SP - 269

EP - 281

JO - Journal of Controlled Release

JF - Journal of Controlled Release

ER -